QS Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $15.9M | Buy |
28,477
+658
| +2% | +$333K | 0.19% | 81 |
|
|
2021
Q1 | $13.2M | Buy |
27,819
+6,156
| +28% | +$3M | 0.15% | 106 |
|
|
2020
Q4 | $10.5M | Buy |
21,663
+1,155
| +6% | +$623K | 0.13% | 131 |
|
|
2020
Q3 | $11.5M | Buy |
20,508
+326
| +2% | +$198K | 0.15% | 115 |
|
|
2020
Q2 | $12.6M | Sell |
20,182
-5,297
| -21% | -$3.01M | 0.18% | 101 |
|
|
2020
Q1 | $12.4M | Buy |
25,479
+10,330
| +68% | +$4.26M | 0.2% | 90 |
|
|
2019
Q4 | $5.66M | Buy |
15,149
+140
| +0.9% | +$47.1K | 0.06% | 250 |
|
|
2019
Q3 | $4.16M | Sell |
15,009
-36
| -0.2% | -$10.7K | 0.05% | 322 |
|
|
2019
Q2 | $4.71M | Buy |
15,045
+4,166
| +38% | +$1.39M | 0.05% | 288 |
|
|
2019
Q1 | $4.47M | Buy |
10,879
+7,694
| +242% | +$3.17M | 0.05% | 302 |
|
|
2018
Q4 | $1.19M | Hold |
3,185
| – | – | 0.02% | 722 |
|
|
2018
Q3 | $1.29M | Sell |
3,185
-778
| -20% | -$296K | 0.01% | 753 |
|
|
2018
Q2 | $1.37M | Hold |
3,963
| – | – | 0.01% | 709 |
|
|
2018
Q1 | $1.36M | Hold |
3,963
| – | – | 0.01% | 700 |
|
|
2017
Q4 | $1.49M | Buy |
3,963
+184
| +5% | +$74.5K | 0.01% | 687 |
|
|
2017
Q3 | $1.69M | Sell |
3,779
-65
| -2% | -$30.9K | 0.01% | 662 |
|
|
2017
Q2 | $1.89M | Sell |
3,844
-12,359
| -76% | -$5.41M | 0.02% | 610 |
|
|
2017
Q1 | $6.28M | Sell |
16,203
-4,770
| -23% | -$1.77M | 0.05% | 235 |
|
|
2016
Q4 | $7.7M | Sell |
20,973
-95
| -0.5% | -$36.1K | 0.06% | 216 |
|
|
2016
Q3 | $8.47M | Sell |
21,068
-1,233
| -6% | -$495K | 0.07% | 235 |
|
|
2016
Q2 | $7.79M | Sell |
22,301
-662
| -3% | -$255K | 0.07% | 262 |
|
|
2016
Q1 | $8.28M | Sell |
22,963
-4,760
| -17% | -$1.96M | 0.08% | 246 |
|
|
2015
Q4 | $15.1M | Buy |
27,723
+189
| +0.7% | +$102K | 0.15% | 131 |
|
|
2015
Q3 | $12.8M | Buy |
27,534
+4,350
| +19% | +$2.34M | 0.13% | 143 |
|
|
2015
Q2 | $11.8M | Sell |
23,184
-3,295
| -12% | -$1.61M | 0.15% | 162 |
|
|
2015
Q1 | $12M | Sell |
26,479
-7,055
| -21% | -$2.99M | 0.14% | 178 |
|
|
2014
Q4 | $13.8M | Buy |
33,534
+31,131
| +1,296% | +$12.2M | 0.16% | 157 |
|
|
2014
Q3 | $866K | Sell |
2,403
-300
| -11% | -$101K | 0.02% | 376 |
|
|
2014
Q2 | $764K | Buy |
2,703
+1,111
| +70% | +$329K | 0.02% | 420 |
|
|
2014
Q1 | $478K | Sell |
1,592
-400
| -20% | -$123K | 0.01% | 458 |
|
|
2013
Q4 | $550K | Sell |
1,992
-200
| -9% | -$57.5K | 0.02% | 412 |
|
|
2013
Q3 | $685K | Sell |
2,192
-408
| -16% | -$107K | 0.03% | 389 |
|
|
2013
Q2 | $592K | Buy |
+2,600
| New | +$605K | 0.02% | 488 |
|
Other funds holding REGN
QS Investors's REGN Position: Q2 2021 in Review
QS Investors increased its Regeneron Pharmaceuticals (REGN) stake by 2.4% in Q2 2021, buying an estimated $333K and bringing the position to 28,477 shares worth $15.9M. The position accounts for 0.19% of the portfolio, ranked #81.
QS Investors first reported a position in REGN in Q2 2013 and has held it in 33 quarters since. 971 funds tracked by Wall St. Rank hold REGN as of Q2 2021.
- QS Investors held 28,477 shares of Regeneron Pharmaceuticals worth $15.9M as of Q2 2021.
- QS Investors bought 658 Regeneron Pharmaceuticals shares in Q2 2021, an estimated $333K.
- Regeneron Pharmaceuticals made up 0.19% of QS Investors's portfolio in Q2 2021, its #81 holding.
- QS Investors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
- 971 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.